Difference between revisions of "Team:Calgary"

Line 265: Line 265:
 
                 <a href="https://albertainnovates.ca/"
 
                 <a href="https://albertainnovates.ca/"
 
                   ><img
 
                   ><img
                     src="https://static.igem.org/mediawiki/2019/e/e5/T--Calgary--Logo_Alberta_Innovates.svg"
+
                     src="https://static.igem.org/mediawiki/2020/7/70/T--Calgary--AlbertaInnovates.jpg"
 
                 /></a>
 
                 /></a>
 
               </div>
 
               </div>
Line 283: Line 283:
 
                 <a href="https://www.benchling.com/"
 
                 <a href="https://www.benchling.com/"
 
                   ><img
 
                   ><img
                     src="https://static.igem.org/mediawiki/2019/3/36/T--Calgary--Benchling.png"
+
                     src="https://static.igem.org/mediawiki/2020/3/36/T--Calgary--Benchling.png"
 
                 /></a>
 
                 /></a>
 
               </div>
 
               </div>

Revision as of 14:47, 27 October 2020



A MAJOR PROBLEM


VITAMIN A DEFICIENCY IS A LEADING CAUSE OF CHILDHOOD MORTALITY AND BLINDNESS.
WE'RE HERE TO CHANGE THAT.

OVIITA DESIGN


As a leading global cause of preventable blindness and mortality, vitamin A deficiency (VAD) is a serious health problem, particularly in developing regions. Oviita aims to equip these vulnerable regions with a sustainable and community-based solution to VAD. Our solution uses a food-safe strain of Yarrowia lipolytica modified to produce beta-carotene, a Vitamin A precursor. By engineering this yeast to produce cellulase, VAD communities can grow it as their own vitamin A supplement using readily-available plant matter as feedstock. To facilitate community integration, we designed bioreactor schematics based on locally-available resources, and made the yeast auxotrophic to ensure safe growth with no environmental risk. We also created a Vitamin A biosensor to improve VAD testing, and included an anthelmintic agent in the yeast to combat poor intestinal health, two contributing factors to VAD. Through these solutions, Oviita aims to be a sustainable and community-based adjunct to global efforts against VAD.

1 / 3
Caption Text
2 / 3
Caption Two
3 / 3
Caption Three